Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ketamine Infusions for Pain in Acute Burn Injury
NCT03095222Phase 4Withdrawn
- Sponsor
- University of Kansas Medical Center
- Start
- Apr 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in pain, sponsored by University of Kansas Medical Center. Planned start Apr 2017; status: withdrawn.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03095222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095222.